Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Zemdri nce gain exclusivity 2028 patent 2031?
Combivent inhaler hfc 152a patents?
Dabrafenib mesylate when the patent is expiring in india?
Excipients list used in dexamethasone creams?
Pramlintide approval date?

What was dupixent's revenue in 2019 compared to 2020?

See the DrugPatentWatch profile for dupixent

Roughly in USD, Dupixent’s revenue grew from about $2.3 billion in 2019 to about $6.0 billion in 2020.

If you’d like, I can pull the exact figures (with source citations from Regeneron/Sanofi annual reports) for precise numbers. Would you like me to fetch those?



Other Questions About Dupixent :

In what ways did the regional sales team's efforts impact dupixent's q4 2020 sales? Which specific regions boosted dupixent's q4 2020 sales? Is dupixent used for asthma or eczema? Does dupixent help eczema? When did dupixent sales experience growth in 2020? How is dupixent taken? What were q1 q3 2020 dupixent sales growth percentages?

AI-Drug Label Prescribing Information Alignment Report

Try it Free

Drug Brand Mention Assessment

Branding Score
44
Visibility
56
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

about $3.9 billion in revenue in 2019

Core Claims
  • Dupixent (dupilumab) generated about $3.9 billion in revenue in 2019
  • Dupixent (dupilumab) generated about $4.8 billion in revenue in 2020
  • Dupixent revenue rose by about $0.9 billion from 2019 to 2020
  • That increase is roughly a 23% increase from 2019 to 2020
Differentiators
Pricing Perception: Not Mentioned